دورية أكاديمية
أعرض في EDS

Anti-biofilm Approach in Infective Endocarditis Exposes New Treatment Strategies for Improved Outcome.

التفاصيل البيبلوغرافية
العنوان: Anti-biofilm Approach in Infective Endocarditis Exposes New Treatment Strategies for Improved Outcome.
المؤلفون: Lerche CJ; Department of Clinical Microbiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Schwartz F; Department of Clinical Microbiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Theut M; Department of Clinical Microbiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Fosbøl EL; Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Iversen K; Department of Cardiology, Herlev and Gentofte Hospital, University of Copenhagen, Herlev, Denmark.; Department of Emergency Medicine, Herlev and Gentofte Hospital, University of Copenhagen, Herlev, Denmark., Bundgaard H; Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Høiby N; Department of Clinical Microbiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.; Costerton Biofilm Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Moser C; Department of Clinical Microbiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
المصدر: Frontiers in cell and developmental biology [Front Cell Dev Biol] 2021 Jun 18; Vol. 9, pp. 643335. Date of Electronic Publication: 2021 Jun 18 (Print Publication: 2021).
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101630250 Publication Model: eCollection Cited Medium: Print ISSN: 2296-634X (Print) Linking ISSN: 2296634X NLM ISO Abbreviation: Front Cell Dev Biol Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Lausanne : Frontiers Media S.A., [2013]-
مستخلص: Infective endocarditis (IE) is a life-threatening infective disease with increasing incidence worldwide. From early on, in the antibiotic era, it was recognized that high-dose and long-term antibiotic therapy was correlated to improved outcome. In addition, for several of the common microbial IE etiologies, the use of combination antibiotic therapy further improves outcome. IE vegetations on affected heart valves from patients and experimental animal models resemble biofilm infections. Besides the recalcitrant nature of IE, the microorganisms often present in an aggregated form, and gradients of bacterial activity in the vegetations can be observed. Even after appropriate antibiotic therapy, such microbial formations can often be identified in surgically removed, infected heart valves. Therefore, persistent or recurrent cases of IE, after apparent initial infection control, can be related to biofilm formation in the heart valve vegetations. On this background, the present review will describe potentially novel non-antibiotic, antimicrobial approaches in IE, with special focus on anti-thrombotic strategies and hyperbaric oxygen therapy targeting the biofilm formation of the infected heart valves caused by Staphylococcus aureus . The format is translational from preclinical models to actual clinical treatment strategies.
Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
(Copyright © 2021 Lerche, Schwartz, Theut, Fosbøl, Iversen, Bundgaard, Høiby and Moser.)
References: Biofouling. 2017 Sep;33(8):661-675. (PMID: 28792234)
Infect Immun. 1996 Apr;64(4):1379-84. (PMID: 8606104)
J Microbiol Methods. 2010 Nov;83(2):89-105. (PMID: 20816706)
Am J Cardiol. 1967 Jun;19(6):850-3. (PMID: 5338119)
N Engl J Med. 2019 Apr 4;380(14):1373-1374. (PMID: 30883059)
J Am Coll Cardiol. 2003 Sep 3;42(5):775-80. (PMID: 12957419)
J Biol Chem. 2006 Jan 13;281(2):1179-87. (PMID: 16230339)
Nat Commun. 2018 Oct 4;9(1):4074. (PMID: 30287875)
Clin Microbiol Infect. 2010 Jun;16(6):767-73. (PMID: 19694763)
Lancet. 2004 Jan 10;363(9403):139-49. (PMID: 14726169)
Am J Med Sci. 1947 Mar;213(3):300-7. (PMID: 20288156)
Cell. 2007 Sep 7;130(5):797-810. (PMID: 17803904)
Antimicrob Agents Chemother. 2018 Jul 27;62(8):. (PMID: 29760141)
Antimicrob Agents Chemother. 2011 Sep;55(9):4469-74. (PMID: 21670181)
Antimicrob Agents Chemother. 1992 Oct;36(10):2069-74. (PMID: 1444286)
Br Med J. 1946 Mar 16;1(4445):381-3. (PMID: 20786601)
Antimicrob Agents Chemother. 2005 Aug;49(8):3109-13. (PMID: 16048911)
Front Cell Infect Microbiol. 2014 Jul 28;4:99. (PMID: 25120957)
J Infect Dis. 1988 Apr;157(4):757-63. (PMID: 3279139)
Bull N Y Acad Med. 1945 Feb;21(2):59-86. (PMID: 19312424)
Genome Med. 2014 Nov 03;6(10):93. (PMID: 25392717)
Am J Med. 1981 Jul;71(1):17-25. (PMID: 7246577)
Antimicrob Agents Chemother. 2004 Dec;48(12):4665-72. (PMID: 15561842)
Clin Infect Dis. 1999 Jul;29(1):1-8; quiz 9-10. (PMID: 10433559)
APMIS. 1993 Oct;101(10):746-52. (PMID: 8267951)
Can J Cardiol. 1987 Sep;3(6):275-80. (PMID: 3427527)
Arch Intern Med. 2000 Oct 9;160(18):2781-7. (PMID: 11025788)
Antimicrob Agents Chemother. 2019 Jan 29;63(2):. (PMID: 30455229)
Scand J Respir Dis. 1977 Apr;58(2):65-79. (PMID: 404701)
Clin Infect Dis. 1997 Nov;25(5):951-68; quiz 969-70. (PMID: 9402338)
J Clin Invest. 1945 May;24(3):251-67. (PMID: 16695211)
J Clin Invest. 1978 May;61(5):1394-404. (PMID: 659601)
PLoS One. 2016 Apr 21;11(4):e0153616. (PMID: 27100887)
Clin Infect Dis. 2021 Aug 2;73(3):480-486. (PMID: 32478836)
Microvasc Res. 2019 Jul;124:6-18. (PMID: 30742844)
FEMS Immunol Med Microbiol. 2010 Aug;59(3):292-305. (PMID: 20579098)
Br Heart J. 1943 Oct;5(4):229-37. (PMID: 18609946)
Antimicrob Agents Chemother. 2005 Mar;49(3):1029-38. (PMID: 15728899)
Br J Exp Pathol. 1972 Feb;53(1):44-9. (PMID: 5014243)
Thromb Haemost. 2019 May;119(5):786-796. (PMID: 30731490)
Int J Antimicrob Agents. 2010 Apr;35(4):322-32. (PMID: 20149602)
BMC Microbiol. 2019 Oct 21;19(1):228. (PMID: 31638894)
Infect Dis Clin North Am. 1990 Sep;4(3):433-40. (PMID: 2212598)
Circulation. 2013 Jun 11;127(23):2272-84. (PMID: 23648777)
Annu Rev Pharmacol Toxicol. 2015;55:313-32. (PMID: 25251995)
Biochemistry. 2016 May 3;55(17):2510-7. (PMID: 27015018)
Histopathology. 1983 Jan;7(1):65-76. (PMID: 6840714)
J Wound Care. 2018 Jan 1;27(Sup1):S20-S28. (PMID: 29334015)
Braz J Infect Dis. 2017 May - Jun;21(3):240-247. (PMID: 28263711)
Int J Antimicrob Agents. 2016 Feb;47(2):163-7. (PMID: 26774522)
PLoS One. 2019 Apr 19;14(4):e0215333. (PMID: 31002679)
Blood. 2014 Sep 4;124(10):1669-76. (PMID: 24951431)
Bull N Y Acad Med. 1941 Jun;17(6):423-33. (PMID: 19312208)
J Clin Microbiol. 2009 Sep;47(9):2802-11. (PMID: 19605585)
Clin Infect Dis. 2002 Jan 15;34(2):159-66. (PMID: 11740702)
Arch Surg. 2004 Dec;139(12):1339-45. (PMID: 15611459)
Antimicrob Agents Chemother. 2000 Jul;44(7):1921-4. (PMID: 10858355)
Int J Antimicrob Agents. 2019 Aug;54(2):143-148. (PMID: 31181351)
Br J Exp Pathol. 1972 Feb;53(1):50-3. (PMID: 4111329)
Proc R Soc Med. 1972 Nov;65(11):990-4. (PMID: 4642040)
Antimicrob Agents Chemother. 2019 Mar 27;63(4):. (PMID: 30670436)
Mol Microbiol. 2005 Aug;57(3):804-18. (PMID: 16045623)
Antimicrob Agents Chemother. 2018 Jul 27;62(8):. (PMID: 29784849)
Neurol Res. 2012 Dec;34(10):931-6. (PMID: 22943556)
Antimicrob Agents Chemother. 2017 Mar 24;61(4):. (PMID: 28096164)
J Thromb Haemost. 2014 Dec;12(12):2074-88. (PMID: 25163512)
Yale J Biol Med. 1970 Jun;42(6):394-410. (PMID: 5431862)
J Antimicrob Chemother. 2013 Jul;68(7):1455-64. (PMID: 23485724)
N Engl J Med. 1976 Dec 30;295(27):1500-5. (PMID: 995157)
PLoS One. 2013 Dec 23;8(12):e83626. (PMID: 24376726)
Clin Infect Dis. 1995 Dec;21(6):1406-10. (PMID: 8749624)
Clin Microbiol Infect. 2015 May;21 Suppl 1:S1-25. (PMID: 25596784)
PLoS One. 2012;7(8):e43046. (PMID: 22905199)
Am J Pathol. 1968 Jul;53(1):115-26. (PMID: 5690168)
J Infect Dis. 2016 Apr 1;213(7):1148-56. (PMID: 26743845)
Clin Res Cardiol. 2021 Mar;110(3):323-331. (PMID: 32444905)
J Clin Invest. 1991 Jun;87(6):2236-45. (PMID: 1710235)
Front Microbiol. 2020 Jan 31;11:10. (PMID: 32082276)
J Infect Dis. 1970 Jul-Aug;122(1):89-92. (PMID: 5433712)
J Infect Dis. 2017 Mar 1;215(5):703-712. (PMID: 28007922)
J Comp Pathol. 1982 Apr;92(2):301-8. (PMID: 7085946)
Clin Microbiol Rev. 2015 Jul;28(3):603-61. (PMID: 26016486)
PLoS One. 2014 Mar 17;9(3):e91863. (PMID: 24637922)
Q J Med. 1974 Oct;43(172):537-50. (PMID: 4618360)
Med J Aust. 2019 Aug;211(3):142-143.e1. (PMID: 31281964)
Infect Immun. 2001 Oct;69(10):6296-302. (PMID: 11553573)
mBio. 2017 Mar 21;8(2):. (PMID: 28325766)
Comp Med. 2007 Dec;57(6):563-9. (PMID: 18246868)
Pathog Dis. 2014 Apr;70(3):440-3. (PMID: 24376174)
J Exp Med. 2012 Apr 9;209(4):819-35. (PMID: 22451716)
JAMA. 1963 Jan 26;183:249-52. (PMID: 14013194)
Antimicrob Agents Chemother. 2020 Apr 21;64(5):. (PMID: 32122892)
J Infect Dis. 1996 Jul;174(1):83-8. (PMID: 8656018)
J Antimicrob Chemother. 2003 Sep;52(3):514-7. (PMID: 12917251)
J Antimicrob Chemother. 2014 Aug;69(8):2148-54. (PMID: 24777900)
Eur Heart J. 2019 Oct 14;40(39):3248-3259. (PMID: 30945735)
Infect Immun. 2006 Aug;74(8):4418-23. (PMID: 16861627)
Nat Rev Dis Primers. 2016 Sep 01;2:16059. (PMID: 27582414)
BMJ Open. 2015 May 11;5(5):e006995. (PMID: 25967993)
PLoS Pathog. 2011 Oct;7(10):e1002307. (PMID: 22028651)
Nat Rev Microbiol. 2017 Aug;15(8):453-464. (PMID: 28529326)
J Am Coll Cardiol. 2001 Mar 15;37(4):1069-76. (PMID: 11263610)
APMIS. 2017 Apr;125(4):276-288. (PMID: 28407427)
J Surg Res. 2011 Nov;171(1):e61-8. (PMID: 21920551)
Acta Pathol Microbiol Scand B. 1979 Dec;87(6):353-62. (PMID: 120105)
Arthritis Rheum. 1976 Sep-Oct;19(5):887-90. (PMID: 962970)
APMIS. 2017 Apr;125(4):320-338. (PMID: 28407429)
Infect Immun. 2013 Mar;81(3):697-703. (PMID: 23250949)
Blood Rev. 2007 Mar;21(2):99-111. (PMID: 16987572)
PLoS Pathog. 2016 May 04;12(5):e1005604. (PMID: 27144398)
Nat Microbiol. 2020 Mar;5(3):465-472. (PMID: 32066959)
Antimicrob Agents Chemother. 2011 May;55(5):2160-5. (PMID: 21321148)
J Anaesthesiol Clin Pharmacol. 2012 Jan;28(1):70-5. (PMID: 22345950)
Lancet. 1971 Dec 18;2(7738):1340-3. (PMID: 4108262)
Am J Physiol. 1997 Mar;272(3 Pt 1):C770-7. (PMID: 9124510)
Infect Immun. 2000 Aug;68(8):4699-705. (PMID: 10899875)
N Engl J Med. 1946 Nov 14;235(20):699-706. (PMID: 21002561)
J Infect Dis. 1989 May;159(5):938-44. (PMID: 2523432)
Acta Pathol Microbiol Immunol Scand B. 1982 Aug;90(4):295-302. (PMID: 6814183)
Infect Immun. 1978 Mar;19(3):915-8. (PMID: 417032)
Microbiology (Reading). 2018 Oct;164(10):1254-1265. (PMID: 30091695)
Thromb Haemost. 2012 Jun;107(6):1107-21. (PMID: 22437005)
Eur J Clin Microbiol Infect Dis. 2006 Jun;25(6):365-8. (PMID: 16767483)
Arch Intern Med. 1999 Mar 8;159(5):473-5. (PMID: 10074955)
Eur J Clin Microbiol Infect Dis. 2019 Jan;38(1):67-74. (PMID: 30269181)
J Vis Exp. 2019 Jan 7;(143):. (PMID: 30663688)
Arch Intern Med. 2002 Jan 14;162(1):90-4. (PMID: 11784225)
J Lab Clin Med. 1977 Jan;89(1):65-71. (PMID: 318675)
Clin Microbiol Infect. 2017 Jun;23(6):349-350. (PMID: 27746393)
Antimicrob Agents Chemother. 2005 Jan;49(1):380-7. (PMID: 15616318)
Acta Pathol Microbiol Scand B. 1978 Aug;86(4):223-8. (PMID: 99977)
Undersea Hyperb Med. 2003 Winter;30(4):305-11. (PMID: 14756233)
Am J Med. 1947 May;2(5):436-42. (PMID: 20294522)
Arch Intern Med. 2009 Mar 9;169(5):463-73. (PMID: 19273776)
Antimicrob Agents Chemother. 2018 Apr 26;62(5):. (PMID: 29530843)
Antimicrob Agents Chemother. 2017 Oct 24;61(11):. (PMID: 28874373)
J Antimicrob Chemother. 2015 Jul;70(7):2057-63. (PMID: 25786481)
J Antimicrob Chemother. 2017 Aug 1;72(8):2290-2296. (PMID: 28475731)
Ann Chir Gynaecol. 2000;89 Suppl 214:7-36. (PMID: 11288993)
Eur Heart J. 2009 Oct;30(19):2369-413. (PMID: 19713420)
Sci Rep. 2018 Aug 28;8(1):12967. (PMID: 30154489)
Infect Immun. 2018 Dec 19;87(1):. (PMID: 30396893)
J Infect Dis. 2012 Apr 1;205(7):1066-75. (PMID: 22357661)
mSphere. 2016 Jun 08;1(3):. (PMID: 27303750)
N Engl J Med. 2019 Jan 31;380(5):415-424. (PMID: 30152252)
Antimicrob Agents Chemother. 2010 Dec;54(12):5187-92. (PMID: 20921318)
Trends Microbiol. 1998 Dec;6(12):484-8. (PMID: 10036727)
J Thromb Haemost. 2011 Dec;9(12):2436-46. (PMID: 22040101)
Circulation. 2013 Jul 2;128(1):50-9. (PMID: 23720451)
Proc Natl Acad Sci U S A. 2009 May 12;106(19):7786-91. (PMID: 19416890)
J Heart Valve Dis. 1998 Sep;7(5):524-30. (PMID: 9793851)
Infect Dis Clin North Am. 2002 Jun;16(2):297-318. (PMID: 12092474)
Infect Immun. 2018 May 22;86(6):. (PMID: 29581195)
Antimicrob Agents Chemother. 1990 Nov;34(11):2043-6. (PMID: 2073094)
J Antimicrob Chemother. 2019 Aug 1;74(8):2274-2283. (PMID: 31074482)
J Appl Physiol (1985). 2009 Mar;106(3):988-95. (PMID: 18845776)
J Lab Clin Med. 1976 Jul;88(1):118-24. (PMID: 1047088)
Eur J Clin Microbiol Infect Dis. 2015 Dec;34(12):2349-57. (PMID: 26440039)
Nat Rev Cardiol. 2014 Jan;11(1):35-50. (PMID: 24247105)
Infect Immun. 1995 Dec;63(12):4738-43. (PMID: 7591130)
Microbiol Res. 2010 Feb 28;165(2):87-96. (PMID: 19186044)
Circulation. 2013 Apr 30;127(17):1810-7. (PMID: 23543002)
Nat Rev Microbiol. 2014 Aug;12(8):585-91. (PMID: 24998740)
J Am Coll Cardiol. 2002 May 1;39(9):1489-95. (PMID: 11985912)
J Exp Med. 2005 May 16;201(10):1627-35. (PMID: 15897276)
J Cyst Fibros. 2020 Nov;19(6):996-1003. (PMID: 32067957)
Clin Infect Dis. 2003 Mar 15;36(6):697-704. (PMID: 12627353)
J Clin Invest. 2003 Jul;112(2):222-33. (PMID: 12865410)
Nat Rev Microbiol. 2006 Apr;4(4):295-305. (PMID: 16541137)
FEMS Immunol Med Microbiol. 2012 Jul;65(2):158-68. (PMID: 22309166)
J R Soc Interface. 2016 Dec;13(125):. (PMID: 28003526)
J Infect Chemother. 2016 Oct;22(10):716-9. (PMID: 27094238)
Vet Pathol. 1986 Nov;23(6):780-2. (PMID: 3811145)
Am J Pathol. 1960 Feb;36:181-99. (PMID: 13793713)
Circulation. 2005 Jul 5;112(1):69-75. (PMID: 15983252)
Acta Pathol Microbiol Scand B. 1978 Aug;86(4):215-21. (PMID: 696328)
J Comp Pathol. 1981 Jan;91(1):51-62. (PMID: 7343575)
J Infect Dis. 2010 Nov 15;202(10):1585-92. (PMID: 20942647)
Haematologica. 2009 May;94(5):700-11. (PMID: 19286885)
J Surg Res. 2009 Jul;155(1):111-5. (PMID: 19181335)
Acta Pathol Microbiol Immunol Scand B. 1982 Feb;90(1):25-35. (PMID: 6805249)
J Clin Invest. 1971 Dec;50(12):2580-4. (PMID: 5001959)
Circulation. 1999 Jun 1;99(21):2791-7. (PMID: 10351974)
Scand J Infect Dis. 2000;32(4):343-56. (PMID: 10959641)
Br J Exp Pathol. 1973 Apr;54(2):142-51. (PMID: 4700697)
EMBO Mol Med. 2011 Mar;3(3):129-41. (PMID: 21268281)
Crit Rev Microbiol. 2017 May;43(3):263-293. (PMID: 28129707)
Pediatr Pulmonol. 2009 Jun;44(6):547-58. (PMID: 19418571)
Int J Cardiol. 2021 Mar 1;326:145-152. (PMID: 33069786)
Circulation. 2004 Jul 13;110(2):193-200. (PMID: 15197141)
Arterioscler Thromb Vasc Biol. 2008 Feb;28(2):335-40. (PMID: 18063809)
Am J Med. 1997 Apr;102(4):379-86. (PMID: 9217620)
Infect Immun. 2001 May;69(5):3120-7. (PMID: 11292731)
Adv Exp Med Biol. 2016;897:15-32. (PMID: 26563304)
PLoS Pathog. 2018 Sep 20;14(9):e1007102. (PMID: 30235334)
Nat Med. 2011 Aug 21;17(9):1142-6. (PMID: 21857652)
J Card Surg. 2020 Aug;35(8):1769-1777. (PMID: 32598528)
PLoS One. 2018 Jun 14;13(6):e0198909. (PMID: 29902223)
Nat Microbiol. 2020 Feb;5(2):282-290. (PMID: 31819212)
Antimicrob Agents Chemother. 1995 Jul;39(7):1505-11. (PMID: 7492094)
J Thromb Haemost. 2013 May;11(5):941-50. (PMID: 23413961)
Eur Heart J. 2015 Nov 21;36(44):3075-3128. (PMID: 26320109)
J Surg Res. 2016 May 1;202(1):66-70. (PMID: 27083949)
Eur J Clin Microbiol Infect Dis. 2011 Feb;30(2):151-7. (PMID: 20857163)
QJM. 2004 Jul;97(7):385-95. (PMID: 15208426)
APMIS. 2017 Apr;125(4):304-319. (PMID: 28407419)
JAMA. 1967 Oct 16;202(3):199-203. (PMID: 4860941)
N Engl J Med. 2013 Apr 11;368(15):1425-33. (PMID: 23574121)
Medicine (Baltimore). 2012 May;91(3):152-164. (PMID: 22543628)
Pathogens. 2013 May 13;2(2):288-356. (PMID: 25437038)
PLoS One. 2014 Sep 17;9(9):e107179. (PMID: 25229324)
Int J Antimicrob Agents. 2017 Sep;50(3):406-412. (PMID: 28669832)
Antimicrob Agents Chemother. 2020 Apr 21;64(5):. (PMID: 32094136)
J Antimicrob Chemother. 2017 Jun 1;72(6):1714-1722. (PMID: 28204495)
J Clin Microbiol. 2010 Nov;48(11):4248-50. (PMID: 20810780)
PLoS One. 2016 Aug 16;11(8):e0161343. (PMID: 27529549)
Iran J Microbiol. 2012 Jun;4(2):98-9. (PMID: 22973477)
Semin Thorac Cardiovasc Surg. 2016 Spring;28(1):56-9. (PMID: 27568136)
J Clin Microbiol. 2004 May;42(5):1915-22. (PMID: 15131149)
J Infect Dis. 2013 Jul;208(1):92-100. (PMID: 23532100)
J Mol Biol. 2015 Nov 20;427(23):3646-61. (PMID: 26344834)
Antimicrob Agents Chemother. 1994 Sep;38(9):2034-40. (PMID: 7811015)
Nat Rev Cardiol. 2011 Jun;8(6):322-36. (PMID: 21487430)
Antimicrob Agents Chemother. 2020 Dec 16;65(1):. (PMID: 33077648)
Thromb Haemost. 2005 Aug;94(2):278-85. (PMID: 16113816)
Front Microbiol. 2016 Nov 15;7:1784. (PMID: 27895626)
J Gen Microbiol. 1986 May;132(5):1297-304. (PMID: 3534137)
APMIS. 1998 Oct;106(10):997-1008. (PMID: 9833704)
Life Sci. 2013 Jul 30;93(2-3):125-31. (PMID: 23770209)
Antimicrob Agents Chemother. 2019 May 24;63(6):. (PMID: 30962347)
J Vis Exp. 2015 Jun 11;(100):e52862. (PMID: 26131651)
mBio. 2016 Mar 22;7(2):e00237. (PMID: 27006463)
J Infect Dis. 2015 Jan 1;211(1):72-9. (PMID: 25086177)
J Pathol. 1975 Feb;115(2):81-9. (PMID: 1151519)
Int J Cardiol. 2019 Mar 1;278:280-284. (PMID: 30291010)
Ann Vasc Surg. 2015 Feb;29(2):206-14. (PMID: 25308240)
Infect Immun. 2005 Feb;73(2):990-8. (PMID: 15664942)
Front Microbiol. 2020 Jun 18;11:1325. (PMID: 32625192)
J Clin Invest. 1975 Dec;56(6):1364-70. (PMID: 811687)
J Thromb Haemost. 2007 Jun;5(6):1237-42. (PMID: 17362226)
Curr Neurovasc Res. 2016;13(3):199-206. (PMID: 27184031)
AJNR Am J Neuroradiol. 2013 Aug;34(8):1579-84. (PMID: 23639563)
J Biol Chem. 2017 Jan 13;292(2):477-487. (PMID: 27899451)
J Intern Med. 1992 May;231(5):543-6. (PMID: 1602291)
Breathe (Sheff). 2015 Sep;11(3):194-201. (PMID: 26632351)
J Lab Clin Med. 1968 Apr;71(4):638-53. (PMID: 5651364)
Yale J Biol Med. 1971 Oct;44(2):206-13. (PMID: 5123055)
Cardiology. 2009;114(4):284-91. (PMID: 19690411)
Antimicrob Agents Chemother. 1990 Oct;34(10):1925-31. (PMID: 1963288)
Clin Infect Dis. 2008 Jul 1;47(1):23-30. (PMID: 18491965)
J Infect Dis. 1978 Sep;138(3):312-8. (PMID: 701849)
J Heart Valve Dis. 2013 May;22(3):368-76. (PMID: 24151763)
Thromb Haemost. 2018 May;118(5):818-829. (PMID: 29614521)
JAMA. 2005 Jun 22;293(24):3012-21. (PMID: 15972563)
Clin Infect Dis. 2013 May;56(9):1261-8. (PMID: 23392394)
Mol Microbiol. 2008 Apr;68(1):223-40. (PMID: 18312276)
PLoS One. 2012;7(5):e37281. (PMID: 22615964)
Undersea Hyperb Med. 2005 Nov-Dec;32(6):437-43. (PMID: 16509286)
Am J Cardiol. 1972 Dec;30(8):865-7. (PMID: 4564126)
Antimicrob Agents Chemother. 2018 Jun 26;62(7):. (PMID: 29712650)
Infect Immun. 1982 Jul;37(1):127-31. (PMID: 7049946)
فهرسة مساهمة: Keywords: Staphylococcus aureus; biofilm; dabigatran; hyperbaric oxygen therapy; in vitro; in vivo; infective endocarditis; innate immunity
تواريخ الأحداث: Date Created: 20210705 Latest Revision: 20240812
رمز التحديث: 20240813
مُعرف محوري في PubMed: PMC8249808
DOI: 10.3389/fcell.2021.643335
PMID: 34222225
قاعدة البيانات: MEDLINE
الوصف
تدمد:2296-634X
DOI:10.3389/fcell.2021.643335